AZURE CELL THERAPIES

Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases

#Financial #More

AZURE CELL THERAPIES

Industry:
Biopharma Biotechnology Medical

Founded:
2024-01-01

Address:
Geneva, Geneve, Switzerland

Country:
Switzerland

Status:
Active

Total Funding:
50 K CHF


Investors List

masschallenge-switzerland_image

MassChallenge Switzerland

MassChallenge Switzerland investment in Non Equity Assistance - Azure Cell Therapies

fongit-innovation-fund_image

FONGIT Innovation Fund

FONGIT Innovation Fund investment in Grant - Azure Cell Therapies

More informations about "Azure Cell Therapies"

Azure Cell Therapies - LinkedIn

Meet Bilal Fares, CEO of Azure Cell Therapies, who is advancing regenerative medicine with next-generation cell therapies for Parkinsonโ€™s disease.Building on two decades of research at the ...See details»

Azure Cell Therapies Company Profile 2025: Valuation, Funding ...

Apr 26, 2024 Azure Cell Therapies General Information Description. Developer of healthcare therapies intended for Parkinson's disease. The company offers cell therapies for Parkinson's โ€ฆSee details»

Azure Cell Therapies - Venturelab

Sep 27, 2024 Although cell therapies bring hope to solve PD by replacing lost brain neurons, current limitations in their safety, scalability and loss of efficacy remain to be addressed. We โ€ฆSee details»

Azur Cell Therapies and Antion Biosciences get funding from

Mar 12, 2025 Azure Cell Therapies has been granted CHF 50โ€™000 to further their work unlocking next-generation cell therapies for this debilitating disease. Emerging from the University of โ€ฆSee details»

Azure Cell Therapies - Company Profile - Tracxn

Feb 17, 2025 Azure Cell Therapies - Company developing innovative cell therapy solutions for the treatment of neurodegenerative diseases. Founded by Bilal Fares and Karl Krause in the โ€ฆSee details»

Azure Cell Therapies - Drug pipelines, Patents, Clinical trials

Last update 23 Jan 2025. Azure Cell Therapies. Private Company |See details»

Azure Cell Therapies | Biopharma, Biotechnology, Medical

Azur Cell Therapies and Antion Biosciences get funding โ€ฆ Nov 29, 2024 Azure Cell Therapies has been granted CHF 50โ€™000 to further their work unlocking next-generation cell therapies for โ€ฆSee details»

Azure Cell, FireFly Fusion et Antion reçoivent le soutien du FIF

Apr 29, 2024 Azure Cell Therapies, issue de lโ€™Université de Genève et dirigée par le Dr Bilal Fares, a reçu une bourse de CHF 50โ€™000 pour accélérer le développement de thérapies โ€ฆSee details»

Startups developing neuron regeneration, waste-to-energy plants ...

Dec 18, 2024 Azure Cell Therapies, Jaipur Robotics, Lemna Bio, and RegCheck were selected at Venture Kick's first financial and entrepreneurial support stage. Their projects push the โ€ฆSee details»

BILAL FARES // Azure Cell Therapies โ€“ W.A. de Vigier Stiftung

BILAL FARES, CEO Azure Cell Therapies Regenerating neurons to defeat Parkinson's Every 9 minutes, someone is diagnosed with Parkinsonโ€™s, a disease that destroys brain cells with no โ€ฆSee details»

Azure Cell Therapies - VentureRadar

Unlocks next-generation cell therapies for Parkinsonโ€™s disease. VentureRadar Research / Company Website. Associated sectors: Biotech; Similar Companies: Serum Bio-technology โ€ฆSee details»

Azure Cell Therapies - Funding, Financials, Valuation & Investors

Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by โ€ฆSee details»

Azure Cell Therapies - Products, Competitors, Financials, โ€ฆ

Azure Cell Therapies's latest funding round is Biz Plan Competition. How much did Azure Cell Therapies raise? Azure Cell Therapies raised a total of $70K. Who are the investors of Azure โ€ฆSee details»

Grant - Azure Cell Therapies - 2024-04-26 - Crunchbase

Apr 29, 2024 Organization Name . Azure Cell Therapies . Announced Date Apr 26, 2024; Funding Type ...See details»

Azure Cell Therapies - startup.ch

Although cell therapies bring hope to solve PD by replacing lost brain neurons, current limitations in their safety, scalability and loss of efficacy remain to be addressed. We are developing the โ€ฆSee details»

Azure Cell Therapies - Founders and Board of Directors - Tracxn

Feb 17, 2025 Co-Founder; at . Azure Cell Therapies. View all details about the team at Azure Cell Therapies. Our Lite Plan Awaits you - Its Free! Sign up now to unlock full access to โ€ฆSee details»

Azure Cell, FireFly Fusion and Antion receive FIF support | GGBa

Apr 29, 2024 Azure Cell Therapies, emerging from the University of Geneva and led by Dr. Bilal Fares, received a CHF 50,000 grant to enhance their development of cell therapies for โ€ฆSee details»

Three Geneva Tech Projects awarded FIF Funding - startupticker.ch

Apr 26, 2024 Azure Cell Therapies has been granted CHF 50,000 to further their work unlocking next-generation cell therapies for this debilitating disease. Emerging from the University of โ€ฆSee details»

Azure Cell Therapies Stock Price, Funding, Valuation, Revenue ...

Dec 18, 2024 See Azure Cell Therapies funding rounds, investors, investments, exits and more. Evaluate their financials based on Azure Cell Therapies's post-money valuation and revenue.See details»

Federal government announces support for cutting-edge, AI- and โ€ฆ

5 days ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for โ€ฆSee details»

linkstock.net © 2022. All rights reserved